In the single-agent anti-PD1, the toxicity pattern was similar to the non-adjuvant setting, with increasing frequency of hepatitis (9.6%), arthritis (9.6%) and colitis (7.7%) (Figure 3B). This evidence concerns the gene PDCD1 and Hepatitis.